ArticleBMC complementary medicine and therapies2025
Evaluation of antibacterial activity and chemical analysis of clove aqueous extract (Syzygium aromaticum).
Article in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Enrichment of Rapeseed Honey with Combined Polyphenol-Rich Dry Extracts from Mandarin Peels and Clove Buds.Molecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clove (Syzgium aromaticum) is an aromatic historic spice from the Myrtaceae family. The clove's major chemical ingredients are essential oils.Cloves have long been utilized in both traditional and modern medicine. The Myrtaceae family's clove bud (Syzygium aromaticum) is regarded as one of the most efficient and important antibacterial natural herbs.The aim of the present study was to evaluate the antibacterial properties of clove aqueous extracts (Syzygium aromaticum) and its chemical characterization. To verify the nature of the antibacterial agent (s) of clove.Clove aqueous extract was evaluated for antibacterial activity in vitro against 10 Gram-positive and Gram-negative standard organisms using well diffusion method, Campylobacter coli (C. coli): ATCC:43478, ATCC: Enterobacter aerogenes (E. aerogenes): ATCC: 13048, Enterococcus faecalis (E. faecalis): ATCC: 29212, Escherichia coli (E. coli): ATCC: 25922. Klebsiella pneumoniae (K. pneumoniae): ATCC: 700603, Listeria monocytogenes (L. monocytogenes): ATCC 35152, Pseudomonas aeruginosa (P. aeruginosa): ATCC: 27853, Shigella sonnei (S. sonnei): ATCC12022, Staphylococcus aureus (S. aureus): ATCC: 29213, and Staphylococcus Methicillin Resistant MRSA: ATCC: 2359.Clove ethyl acetate extract was subjected to Gas chromatography-Mass spectrometer GC-MS for chemical characterization.Clove aqueous extract exerted a potent antimicrobial activity against the 10 standard organisms.Substantial broad spectrum antibacterial activity was reported in clove aqueous extract against 10 common Gram-positive and Gram-negative bacteria. E. coli and K. pneumoniae were found to be the most sensitive bacteria to the clove aqueous extract. Clove's chemical makeup was identified using GC-MS. 58 different chemicals in total were found. Eugenol has the highest concentration (53.24).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.